Idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia is a deadly disease with no
effective treatment. The purpose of this randomised prospective multicentric study was to …

Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic fibrosing interstitial
pneumonia of unknown aetiology and is associated with the histological picture of usual …

Idiopathic pulmonary fibrosis (IPF) is a disease with progressive and devastating
deterioration of lung function and a fatal prognosis, despite aggressive therapeutic attempts …

Context Despite the investigation of multiple therapeutic options, idiopathic pulmonary
fibrosis (IPF) remains a devastating, progressively fatal disease. Much interest has focused …

Background Idiopathic pulmonary fibrosis is a fatal disease for which no effective treatment
exists. We assessed whether treatment with interferon gamma-1b improved survival …

OBJECTIVE To report on observations made in a group of patients with idiopathic
pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP) who were treated with interferon …

Background Idiopathic pulmonary fibrosis is a progressive, fatal disease with no known
efficacious therapy. Methods In a double-blind, multinational trial, we randomly assigned …

Background Idiopathic pulmonary fibrosis (IPF) is a devastating disease, yet validated,
reliable criteria for evaluating patient response to therapies in clinical trials are lacking …

Background: The only proven therapeutic option for idiopathic pulmonary fibrosis (IPF) is
lung transplantation. It is biologically plausible that interferon gamma-1b (G-IFN) may halt or …

Study objectives: In this study we evaluated the role of three currently available therapeutic
regimens in the treatment of early stages of idiopathic pulmonary fibrosis (IPF). Patients: The …